Coronavirus Update: Sinovac Latest To Report Vaccine Success In Humans

Plus News From AZ, Sanofi, Lilly, Junshi And Merck & Co.

Sinovac's candidate is a more conventional inactivated vaccine, but is keeping pace with more modern approaches taken by Moderna and CanSino.  

Graduates
12 June: High School graduates at Bearcat Stadium in Sherman, Texas.

Sinovac Biotech Ltd. has announced positive preliminary Phase I/II trial results for its COVID-19 vaccine candidate, named CoronaVac.

The Beijing-headquartered company has only released limited data from its studies, and has not yet published the results in a...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip